Baker Tilly Wealth Management’s Antares Pharma, Inc. ATRS Stock Holding History

Baker Tilly Wealth Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,201	Closed	-$83K	–	540
2022 Q1	$83K	Sell	20,201 -15,272	-43%	-$55.4K	0.01%	512
2021 Q4	$127K	Buy	35,473 +21,664	+157%	+$75.8K	0.01%	520
2021 Q3	$50K	Buy	+13,809	New	+$55.8K	0.01%	499

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Baker Tilly Wealth Management's ATRS Position: Q2 2022 in Review

Baker Tilly Wealth Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 20,201 shares — an estimated $83K sold.

Baker Tilly Wealth Management first reported a position in ATRS in Q3 2021 and held it in 3 quarters. The position peaked at $127K in Q4 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Baker Tilly Wealth Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Baker Tilly Wealth Management sold 20,201 Antares Pharma, Inc. shares in Q2 2022, an estimated $83K.
Baker Tilly Wealth Management first reported a position in Antares Pharma, Inc. in Q3 2021 and held it in 3 quarters.
Baker Tilly Wealth Management's Antares Pharma, Inc. position peaked at $127K in Q4 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Baker Tilly Wealth Management's 13F filing for Q2 2022, filed 28 Jul 2022.